Subenya Injampa, DVM, Ph.D.
Instructor, Faculty of Medicine
King Mongkut’s Institute of Technology Ladkrabang
Doctor of Philosophy (Tropical Medicine), 2017
Mahidol University, Bangkok, Thailand
Doctor of Veterinary Medicine (D.V.M.), 2009
Kasetsart University, Bangkok, Thailand
International Center for Biotechnology, Osaka University, Japan, Osaka University
Research Institute for Microbial Diseases, Osaka University, Japan
Kasetsart Veterinary Teaching Hospital, Faculty of Veterinary Medicine, Kasetsart University, Thailand
Focusing on studies of human B cell especially producing and engineering antibody against infectious disease for developing to be therapeutic drugs or vaccine and for using as diagnostic test kit, my research conducted has also been looking at the role of antibodies in the treatment of infectious disease and establish the techniques for large scale antibody production.
Previously, I have successfully generated fully human monoclonal antibodies against all serotypes of dengue virus which is one of the most important arthropod-borne viral diseases. These antibodies have become to be one of the candidates for immune therapy. Hence my ongoing research highlights on characterize these antibodies in aspect of immunological and pathophysiological activity. My future research plans are aimed toward others infectious diseases e.g. COVID-19, Chikungunya or Zika virus. My laboratory skills are molecular and immunological techniques and I also do phage display technique which is the technique for producing large amounts of peptides, proteins and antibodies.
1. Injampa S, Muenngern N, Pipattanaboon C, Benjathummarak S, Boonha K, Hananantachai H, et al. Generation and characterization of cross neutralizing human monoclonal antibody against 4 serotypes of dengue virus without enhancing activity. PeerJ. 2017 Nov; 13;5:e4021.
2. Thammasonthijarern N, Puangmanee W, Sriburin P, Injampa S, Chatchen S, Phumirattanaprapin W, Pipattanaboon C, Ramasoota P, Pitaksajjakul P. Human Heavy Chain Antibody Genes Elicited in Thai Dengue Patients during DENV2 Secondary Infection. Jpn J Infect Dis. 2019 Nov;73(2):140-7.